4553.T
TOWA PHARMACEUTICAL CO.,LTD.
プライム · 医薬品 · 医薬品 · JP
JPY 3,650.00
+0.27%Year over year
Reported trailing growth
- Revenue
- +6.5%
- EBITDA
- —
- EBIT
- +4.6%
- EPS
- +11.2%
- Free cash flow
- +122.8%
- Operating cash flow
- +121.7%
Forward estimates
Based on analyst estimates
- Revenue
- +3.7%
- EBITDA
- —
- EPS
- -17.5%
Three-year CAGR
- Revenue
- +16.2%
- EBITDA
- +9.9%
- EBIT
- +6.6%
- Net income
- +6.1%
- EPS
- +6.1%
- Free cash flow
- +82.0%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Mar 1, 2026